A Dose Escalation and Expansion Study of NB002 in Participants With Advanced or Metastatic Solid Tumors
Clinical trial NCT05924906 · UNKNOWN
Trial details
- NCT number
- NCT05924906
- Sponsor
- Suzhou Neologics Bioscience Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2026-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.